retatrutide nonalcoholic steatohepatitis nash trial Analysis of Underscores Need for Targeted Treatment retatrutide nonalcoholic steatohepatitis nash trial

The takeaway This new VA research adds to a growing body of evidence: GLP-1s arent just about weight loss theyre reshaping what long-term health can look like

Hoetzenecker W, Ngeli M, Mehra ET, Jensen AN, Saulite I, Schmid-Grendelmeier P, et al

MEDVi does not produce compounded medications - the company operates as a patient management and telehealth platform coordinating access to independent physicians and licensed pharmacy partners

Matschke, J

Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): A multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial

Regular consumption of dietary fiber has been shown to improve cardiovascular health through various mechanisms, including reducing low-density LDL cholesterol levels, aiding in weight management, enhancing glucose metabolism, supporting healthy blood pressure and reducing chronic inflammation